Home > Legislation > 116th Congress > H.R.19

H.R.19 - Lower Costs, More Cures Act of 2019116th Congress (2019-2020)

Bill

Hide Overview
Sponsor: Rep. Walden, Greg [R-OR-2] (Introduced 12/09/2019)
Committees: House - Energy and Commerce; Ways and Means; Judiciary
Latest Action: House - 12/19/2019 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.  (All Actions)

Tracker:

This bill has the status Introduced

Here are the steps for Status of Legislation:

  1. Introduced

More on This Bill

  • Constitutional Authority Statement
  • CBO Cost Estimates [0]

Subject — Policy Area:

Summary: H.R.19 — 116th Congress (2019-2020)All Information (Except Text)

There is one summary for H.R.19. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (12/09/2019)

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs.

The bill generally

  • limits payment amounts for drugs and biologics under Medicare medical services,
  • reduces cost-sharing under the Medicare prescription drug benefit,
  • modifies certain authorities and requirements under the Medicaid Drug Rebate Program,
  • revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and
  • establishes several reporting requirements for drug manufacturers with respect to drug prices.